Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001477932-19-003214
Filing Date
2019-05-29
Accepted
2019-05-29 16:26:14
Documents
1
Effectiveness Date
2019-05-29
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10491
  Complete submission text file 0001477932-19-003214.txt   11692
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: NV | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-340623 | Film No.: 19862329
SIC: 2673 Plastics, Foil & Coated Paper Bags